Cannabinoid Receptor (CB1) Agonist Treatment in Severe Chronic Anorexia Nervosa

NCT00760695 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

24

Enrollment

OTHER

Sponsor class

Conditions

Anorexia Nervosa

Interventions

DRUG: dronabinol
DRUG: placebo

Sponsor

Odense University Hospital